Auro Pharma Inc, is a Canadian subsidiary of Aurobindo Pharma Ltd. A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations. Auro Pharma's competitive advantage is in obtaining a large portfolio of product approvals backed up by a global standard R&D effort. It offers several non-patented, non-infringing processes with a cost-efficient mega manufacturing environment complying with US FDA, Health Canada, UKMHRA, TGA and EU authorities, Auro Pharma Inc. has over 150 NOCs in Canada. There are several more dossiers under Health Canada review. Auro Pharma is now gearing up to enter in various specialty segments starting 2022.
Stay ahead of the competition with real-time market intelligence and actionable insights.
Disclaimer: All information contained in this database has been researched and compiled from many legitimate sources, believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Dietary Business Intelligence (DBI) ( www.dbi360.com ) accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the database. All information is provided without warranty, and DBI makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained and strongly encourages that upon final material or product selection data points are validated with the supplier.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
